Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of LY2140023 in Hepatic Impaired Participants

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: November 16, 2011
Last updated: January 10, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)